文献
J-GLOBAL ID:202202211635148565
整理番号:22A0436370
DREAM3R: 進行性胸膜中皮腫における第一線治療としての化学療法によるデュルバルマブ: 第3相無作為化試験【JST・京大機械翻訳】
DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial
著者 (17件):
Forde P.
(Johns Hopkins University School of Medicine, Baltimore, MD)
,
Kindler H.
(University of Chicago, Chicago, IL)
,
Zauderer M.
(Memorial Sloan Kettering Cancer Center, New York, NY)
,
Sun Z.
(ECOG-ACRIN Biostatistics Center, Frontier Science Foundation, Boston, MA)
,
Ramalingam S.
(Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA)
,
Anagnostou V.
(Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, MD)
,
Brahmer J.R.
(Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD)
,
Nowak A.K.
(Medical School, University of Western Australia, Perth, WA, Australia)
,
Kok P.S.
(NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia)
,
Brown C.
(NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia)
,
Yip S.
(NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia)
,
Cook A.
(National Centre for Asbestos Related Diseases, University of Western Australia; Medical School, University of Western Australia, WA, WA, Australia)
,
Lesterhuis W.J.
(National Centre for Asbestos Related Diseases, University of Western Australia, WA, WA, Australia)
,
Hughes B.G.M.
(University of Queensland, Brisbane, QLD, Australia)
,
Pavlakis N.
(Royal North Shore Hospital, Sydney, NSW, Australia)
,
Stockler M.R.
(University of Sydney, Sydney, Australia)
,
O’Byrne K.J.
(Princess Alexandra Hospital and Queensland University of Technology, Queensland, QLD, Australia)
資料名:
International Journal of Radiation Oncology, Biology, Physics
(International Journal of Radiation Oncology, Biology, Physics)
巻:
112
号:
2
ページ:
e9-e10
発行年:
2022年
JST資料番号:
B0262B
ISSN:
0360-3016
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)